Correction: Combining Clinical, Pathological, and Demographic Factors Refines Prognosis of Lung Cancer: A Population-Based Study

Por Putila, Joseph, Remick, Scot C., Guo, Nancy Lan
Publicado em 2011

Combining Clinical, Pathological, and Demographic Factors Refines Prognosis of Lung Cancer: A Population-Based Study

Por Putila, Joseph, Remick, Scot C., Guo, Nancy Lan
Publicado em 2011

Barriers to Recruitment of Rural Patients in Cancer Clinical Trials

Por Virani, Shamsuddin, Burke, Lola, Remick, Scot C., Abraham, Jame
Publicado em 2011

Declining Mammography Screening in a State Medicaid Fee-for-Service Program: 1999–2008

Por Bhanegaonkar, Abhijeet, Madhavan, S. Suresh, Khanna, Rahul, Remick, Scot C.
Publicado em 2012

The evolving role of statins in hematopoietic stem and progenitor cell transplantation

Por Hamadani, Mehdi, Craig, Michael D, Gibson, Laura F, Remick, Scot C
Publicado em 2011

Breaking and entering into the CNS: clues from solid tumor and nonmalignant models with relevance to hematopoietic malignancies

Por Basu, Soumit K., Remick, Scot C., Monga, Manish, Gibson, Laura F.
Publicado no Clin Exp Metastasis (2013)

Anaplastic Thyroid Cancer: A Review of Epidemiology, Pathogenesis, and Treatment

Por Nagaiah, Govardhanan, Hossain, Akm, Mooney, Colin J., Parmentier, James, Remick, Scot C.
Publicado em 2011

Ocular surface squamous neoplasia in patients with HIV infection in sub-Saharan Africa

Por Nagaiah, Govardhanan, Stotler, Christy, Orem, Jackson, Mwanda, Walter O., Remick, Scot C.
Publicado em 2010

Definitive Upfront Stereotactic Ablative Radiotherapy Combined with Image-Guided, Intensity Modulated Radiotherapy (IG-IMRT) or IG-IMRT Alone for Locally Advanced Non-Small Cell Lu...

Por Chi, Alexander, Wen, Sijin, Monga, Manish, Almubarak, Mohammed, He, Xiaoqing, Rojanasakul, Yon, Tse, William, Remick, Scot C.
Publicado no PLoS One (2016)

AIDS-Related Non-Hodgkin’s Lymphoma in Sub-Saharan Africa: Current Status and Realities of Therapeutic Approach

Por Mwamba, Peter M., Mwanda, Walter O., Busakhala, NaftaliW., Strother, R. Matthew, Loehrer, Patrick J., Remick, Scot C.
Publicado em 2012

Prostasin may contribute to chemoresistance, repress cancer cells in ovarian cancer, and is involved in the signaling pathways of CASP/PAK2-p34/actin

Por Yan, B-x, Ma, J-x, Zhang, J, Guo, Y, Mueller, M D, Remick, S C, Yu, J J
Publicado em 2014

Phase II Trial of Sorafenib in Patients with Advanced Anaplastic Carcinoma of the Thyroid

Por Savvides, Panayiotis, Nagaiah, Govardhanan, Lavertu, Pierre, Fu, Pingfu, Wright, John J., Chapman, Robert, Wasman, Jay, Dowlati, Afshin, Remick, Scot C.
Publicado em 2013

Cancer Treatment–Related Cardiotoxicity: Current State of Knowledge and Future Research Priorities

Por Shelburne, Nonniekaye, Adhikari, Bishow, Brell, Joanna, Davis, Myrtle, Desvigne-Nickens, Patrice, Freedman, Andrew, Minasian, Lori, Force, Thomas, Remick, Scot C.
Publicado em 2014

Strategies of Dose Escalation in the Treatment of Locally Advanced Non-Small Cell Lung Cancer: Image Guidance and Beyond

Por Chi, Alexander, Nguyen, Nam Phong, Welsh, James S., Tse, William, Monga, Manish, Oduntan, Olusola, Almubarak, Mohammed, Rogers, John, Remick, Scot C., Gius, David
Publicado em 2014

PSP94, an upstream signaling mediator of prostasin found highly elevated in ovarian cancer

Por Ma, J-x, Yan, B-x, Zhang, J, Jiang, B-H, Guo, Y, Riedel, H, Mueller, M D, Remick, S C, Yu, J J
Publicado no Cell Death Dis (2014)

Phase I trial of docetaxel and thalidomide: a regimen based on metronomic therapeutic principles

Por Sanborn, Sharon L., Cooney, Matthew M., Dowlati, Afshin, Brell, Joanna M., Krishnamurthi, Smitha, Gibbons, Joseph, Bokar, Joseph A., Nock, Charles, Ness, Anne, Remick, Scot C.
Publicado em 2008

Phase I Pharmacokinetic and Pharmacodynamic Study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin, an Inhibitor of Heat-Shock Protein 90, in Patients With Advanced Solid Tum...

Por Ramanathan, Ramesh K., Egorin, Merrill J., Erlichman, Charles, Remick, Scot C., Ramalingam, Suresh S., Naret, Cynthia, Holleran, Julianne L., TenEyck, Cynthia J., Ivy, S. Percy, Belani, Chandra P.
Publicado em 2010

Sibling Donor and Recipient Immune Modulation With Atorvastatin for the Prophylaxis of Acute Graft-Versus-Host Disease

Por Hamadani, Mehdi, Gibson, Laura F., Remick, Scot C., Wen, Sijin, Petros, William, Tse, William, Brundage, Kathleen M., Vos, Jeffrey A., Cumpston, Aaron, Bunner, Pamela, Craig, Michael D.
Publicado em 2013

Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers

Por Dowlati, Afshin, Posey, James, Ramanathan, Ramesh K., Rath, Linda, Fu, Pingfu, Chak, Amitabh, Krishnamurthi, Smitha, Brell, Joanna, Ingalls, Stephen, Hoppel, Charles L., Ivy, Percy, Remick, Scot C.
Publicado no Cancer Chemother Pharmacol (2009)

A multi-center phase II study of oxaliplatin, irinotecan, and capecitabine in advanced gastric/gastroesophageal junction carcinoma

Por Brell, Joanna M., Krishnamurthi, Smitha S., Javle, Milind, Saltzman, Joel, Wollner, Ira, Pelley, Robert, Dowlati, Afshin, Kantharaj, Belagodu N., Schluchter, Mark D., Rath, Linda, Ivy, S. Percy, Remick, Scot C.
Publicado em 2008